HOME >> BIOLOGY >> NEWS
Mice unable to synthesize vitamin C should become valuable research tool, scientists say

University of North Carolina at Chapel Hill scientists have successfully developed the world's first mice incapable of synthesizing vitamin C, a nutrient essential for growth and healthy bones, teeth, gums, ligaments and blood vessels. The genetically engineered research mice should become a valuable tool in determining vitamin C's role in health and illness, the scientists say.

Dr. Nobuyo Maeda, professor of pathology and laboratory medicine at the UNC-CH School of Medicine, and her colleagues have previously generated mutant mice that showed high cholesterol and atherosclerotic lesions like those found in humans. Such mice now are used widely in research laboratories throughout the world.

"By inactivating a gene that is a key enzyme in ascorbic acid synthesis, we have generated mice that, like humans, depend on dietary vitamin C," Maeda said. "If they don't receive supplementary ascorbic acid, which is another name for vitamin C, within five weeks they become anemic, begin to lose weight and die."

As levels of vitamin C in the mice's blood drop, small but significant increases in their total cholesterol can be measured along with decreases in high-density lipoproteins, the so-called "good cholesterol," she said. But the most striking effects of insufficient vitamin C in the mice are abnormal changes in the wall of the aorta, the main artery channeling blood from the heart to the body.

"Marginal vitamin C deficiency affects the vascular integrity of mice unable to synthesize ascorbic acid, with potentially profound effects on their susceptibility to vascular diseases," Maeda said.

A current, controversial theory about important common illnesses affecting many people such as heart disease and cancer is that oxidative stress may be an important risk factor for disease development, said Dr. Oliver Smithies, Excellence professor of pathology and laboratory medicine at UNC-CH and Maeda's colleague. That is the basis f
'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
15-May-2000


Page: 1 2 3

Related biology news :

1. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
2. Expanding the genetic code--TSRI scientists synthesize 21-amino-acid bacterium
3. Ohio State chemists synthesize possible new anti-tumor agent
4. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
5. Chemical derived from vitamin-E shows early promise as cancer drug
6. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
7. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
8. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
9. New antioxidants are 100 times more effective than vitamin E
10. Study finds huge variability in vitamin E absorption
11. People with undetermined muscle/bone pain tend to be severely vitamin D deficient

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 13, 2019 , ... ... Peterson, RAC , a regulatory affairs and program management executive with more than ... device industries, has joined the firm as an Expert Consultant. , Robert ...
(Date:11/14/2019)... ... November 13, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a ... FDA approved clinical trial for stem cell treatment of knee osteoarthritis . The first ... a subsidiary of VetStem Biopharma. , In July of 2019, PSC received FDA ...
(Date:11/12/2019)... ... 12, 2019 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), ... of a Global Regulatory Affairs Department, to support Medical Device companies across its ... element to any Medtech organization is more important than Research & Development, Manufacturing ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... 12, 2019 , ... REPROCELL Inc. a stem cell and ... Pharma to provided preclinical screening and drug sensitivity for its portfolio of oncology ... of unique and genetically edited cell lines from various tumors. The data generated ...
(Date:11/12/2019)... BASEL, Switzerland (PRWEB) , ... ... ... leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that ... cancer immunotherapies, has adopted Genedata Biologics® to streamline their R&D ...
(Date:11/12/2019)... ... November 12, 2019 , ... Fiberstar, Inc., ... and beverage industry launched a new innovative website. , After extensive research, ... website offers global visitors updated ingredient usage tables by food application and video ...
(Date:11/12/2019)... Va. (PRWEB) , ... November 12, 2019 , ... ... forensic DNA services, welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, ... Genealogy Service (FGS) to ultimately provide investigative leads to law enforcement through ...
Breaking Biology Technology:
Cached News: